QT
IMVT icon

Quantbot Technologies’s Immunovant IMVT Stock Holding History

Quantbot Technologies’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.9K Sell
2,255
-3,104
-58% -$94.6K ﹤0.01% 1501
2026
Q1 		$133K Buy
5,359
+1,759
+49% +$45.5K 0.01% 1260
2025
Q4 		$91.5K Buy
+3,600
New +$80.3K ﹤0.01% 1434
2023
Q4 		– Sell
-6,700
Closed -$257K – 1776
2023
Q3 		$257K Buy
+6,700
New +$151K 0.02% 829
2023
Q2 		– Sell
-14,437
Closed -$224K – 1744
2023
Q1 		$224K Sell
14,437
-11,689
-45% -$203K 0.02% 874
2022
Q4 		$464K Buy
+26,126
New +$329K 0.03% 595
2022
Q1 		– Sell
-16,213
Closed -$138K – 1826
2021
Q4 		$138K Buy
+16,213
New +$134K 0.01% 810

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Quantbot Technologies's IMVT Position: Q2 2026 in Review

Quantbot Technologies reduced its Immunovant (IMVT) stake by 58% in Q2 2026, selling an estimated $94.6K and leaving 2,255 shares worth $86.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

Quantbot Technologies first reported a position in IMVT in Q4 2021 and has held it in 7 quarters since. The position peaked at $464K in Q4 2022. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Quantbot Technologies held 2,255 shares of Immunovant worth $86.9K as of Q2 2026.
  • Quantbot Technologies sold 3,104 Immunovant shares in Q2 2026, an estimated $94.6K.
  • Immunovant made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1501 holding.
  • Quantbot Technologies first reported a position in Immunovant in Q4 2021 and has held it in 7 quarters since.
  • Quantbot Technologies's Immunovant position peaked at $464K in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.